MALIGNANT LYMPHOGRANULOMATOSIS AND ANTICONVULSANT THERAPY
Authors:
- 12 January 1971
- journal article
- Published by Wiley in Acta Medica Scandinavica
- Vol. 189 (1-6) , 131-136
Abstract
A case is described of a woman who, after three years of diphenylhydantoin therapy because of epilepsia, developed a rapidly lethal condition which at autopsy proved to have the histopathological picture of malignant lymphogranulomatosis. Reticulum cell hyperplasia of the type which has been described as a complication of hydantoin therapy was also present. Malignant lymphoma in a few patients receiving diphenylhydantoin medication has been described earlier. This is the first such case in which microscopically verified malignant changes in liver, spleen and bone marrow have been reported.Keywords
This publication has 21 references indexed in Scilit:
- REPEATED STIMULATION OF THE RETICULOENDOTHELIAL SYSTEM AND THE DEVELOPMENT OF PLASMA-CELL DYSCRASIASThe Lancet, 1970
- The Stokes-Adams syndromeThe American Journal of Medicine, 1969
- Hydantoin-Induced Pseudo-PseudolymphomaAnnals of Internal Medicine, 1968
- Hydantoin lymphadenopathyThe Journal of Pathology and Bacteriology, 1968
- GENERALIZED LYMPHADENOPATHY AS A DRUG REACTION TO HYDANTOINActa Neurologica Scandinavica, 1967
- Mesantoin Lymphadenopathy Morphologically Simulating Hodgkin's DiseaseAnnals of Internal Medicine, 1963
- Lymphoma or drug reaction occurring during hydantoin therapy for epilepsyThe American Journal of Medicine, 1962
- THE EFFECT OF SODIUM DILANTIN ADMINISTRATION UPON THE CHEMISTY OF THE SKIN*Journal of Clinical Investigation, 1960
- Lupus Erythematosus Disseminatus after Administration of MesantoinActa Medica Scandinavica, 1957
- TREATMENT OF EPILEPSY WITH SODIUM DIPHENYL HYDANTOINATEThe Lancet, 1940